Medicine and Dentistry
Abdominal Cancer
33%
Acute Cholecystitis
33%
Adjuvant Chemoradiotherapy
8%
Adjuvant Chemotherapy
12%
Aneurysm
33%
Aortoesophageal Fistula
33%
Bile
9%
Bleeding
25%
Body Mass Index
48%
Common Hepatic Artery
7%
Computer Assisted Tomography
33%
Cross Sectional Study
33%
Endovascular Aneurysm Repair
8%
Esophagojejunostomy
33%
Esophagus Reconstruction
8%
Fistula
8%
Gastrectomy
33%
Gimeracil
33%
Intestine Perforation
8%
Learning Curve
23%
Malignant Neoplasm
8%
Meta-Analysis
33%
Multivariate Analysis
6%
Neoadjuvant Chemotherapy
33%
Neoplasm
6%
Overall Survival
20%
Pancreas Cancer
33%
Pancreas Fistula
6%
Pancreaticoduodenectomy
100%
Peritoneal Fibrosis
33%
Postoperative Complication
33%
Postoperative Hemorrhage
6%
Propensity Score Matching
33%
Pseudoaneurysm
11%
Reoperation
6%
Retrospective Study
8%
Roux-en-Y
33%
Scoring System
33%
Stomach Paresis
6%
Surgical Risk
13%
Systematic Review
33%
Total Stomach Resection
41%
Upper Gastrointestinal Bleeding
7%
Wound Infection
9%
Keyphrases
After Surgery
6%
Area under the Curve
6%
Blood Loss
13%
BMI Index
6%
Bowel Obstruction
6%
Bowel Perforation
13%
Clavien
5%
Computed Tomography
33%
Computed Tomography Score
33%
Cumulative Sum Analysis
5%
Curative Treatment
6%
D2 Gastrectomy
11%
Definition of Obesity
6%
Encapsulating Peritoneal Sclerosis
33%
Enterolysis
20%
External Stent
9%
Gimeracil
33%
Hemorrhagic Cholecystitis
33%
Hepatic Artery Aneurysm
33%
High Body Mass Index
6%
High Incidence
6%
High Mortality
6%
Internal Stent
9%
Lethal Complication
6%
Low BMI
6%
Medical Center
6%
Minimally Invasive Pancreaticoduodenectomy
33%
Non-survivors
13%
Oral Chemotherapeutic
11%
Pancreatic Duct Stent
33%
Peripancreatic Fluid Collection
6%
Peritoneal Dialysis
6%
Platinum Doublets
33%
Postsurgical
6%
Proximal Gastrectomy
33%
Receiver Operating Characteristic Curve
6%
Roux-en-Y Esophagojejunostomy
33%
S-1 Monotherapy
22%
Scoring System
33%
Second Radical
8%
Spleen Preservation
33%
Splenic Vessel
5%
Splenic Vessel Preservation
33%
Surgical Mortality
6%
Surgical Outcomes
33%
Surgical Risk
6%
Survivors
13%
Tertiary Referral
6%
Upfront Resection
27%
Upfront Surgery
33%
